Mateon Therapeutics, Inc. MATN
No live quote for MATN yet.
P/E -0.0×
P/S 0.0×
P/B 1.8×
P/FCF -13.1×
EV/EBITDA 0.0×
EV/Sales 0.0×
FCF Yield -7.6%
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
ROE -4474.3%
ROIC 4159.3%
ROA -3192.9%
Revenue 0.0%
Operating Income 30167.3%
EPS (diluted) -15545.2%
Free Cash Flow 19.8%
Current Ratio 0.0×
Quick Ratio 0.0×
Debt / Equity 0.1×
Net Debt / EBITDA 0.0×
Interest Coverage 1.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2019-12-31